Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Caldwell Nick V.Chief Product Officer |  PTONPELOTON INTERACTIVE, INC.Open-market sale · 10b5-1 plan | SELL | $530K 75.8K sh |
| Jan 13, 2026 traded Jan 9, 2026 |
| 20 | Nakamura KatsufumiSVP, Chief Customer Officer |  ADIANALOG DEVICES INCOpen-market sale | SELL | $151K 500 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 20 | Thygesen Allan C.Director, President and CEO |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $686K 9,799 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 20 | Vashisht RijuSenior Vice President |  GGenpact LTDOpen-market sale · 10b5-1 plan | SELL | $747K 16.0K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 20 | Urist MarshallEVP, Research & Investments |  RPRXRoyalty Pharma plcOpen-market sale · 10b5-1 plan | SELL | $816K 20.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 20 | Dewan SameerSenior Vice President | GGenpact LTD Open-market sale · 10b5-1 plan | SELL | $704K 15.1K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 20 | Vollero AndrewChief Financial Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 100 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 20 | Grayson Blake JeffreyChief Financial Officer | DOCUDOCUSIGN, INC. Open-market sale · 10b5-1 plan | SELL | $455K 6,500 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Friedman Paul ADirector |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $1.03M 1,996 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $1.06M 2,044 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $1.28M 2,432 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Ahn KennethPresident, Hagerty Marketplace |  HGTYHagerty, Inc.Open-market sale · 10b5-1 plan | SELL | $643K 50.0K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 19 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $1.27M 2,450 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Patel AnishCHIEF OPERATING OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $1.34M 48.1K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Howard Justyn RussellDirector, Executive Chair, 10% Owner |  SPTSprout Social, Inc.Open-market sale · 10b5-1 plan | SELL | $428K 40.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Vollero AndrewChief Financial Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $194K 738 sh | Jan 13, 2026 traded Jan 13, 2026 |
| 18 | Rodman David MalcomChief Medical Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $72K 2,170 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 18 | Rodman David MalcomChief Medical Officer | MLYSMineralys Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $205K 6,348 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 18 | Gant Kelli K.See remarks |  HCCWARRIOR MET COAL, INC.Open-market sale · 10b5-1 plan | SELL | $1.00M 10.0K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 18 | Baig SaqibChief Accounting Officer | PTONPELOTON INTERACTIVE, INC. Open-market sale · 10b5-1 plan | SELL | $69K 10.0K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 17 | Ahn KennethPresident, Hagerty Marketplace | HGTYHagerty, Inc. Open-market sale · 10b5-1 plan | SELL | $18K 1,350 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 17 | Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner |  IRMDIRADIMED CORPOpen-market sale | SELL | $11K 112 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $598K 1,135 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $324K 600 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $503K 970 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $254K 473 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $304K 575 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $507K 970 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $758K 1,480 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $261K 487 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $259K 480 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $561K 1,094 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $269K 521 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $366K 691 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $355K 681 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $440K 846 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Brown Justin LPresident/Southwest Gas Corp. |  SWXSouthwest Gas Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $246K 3,028 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $293K 554 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $814K 1,578 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $822K 1,560 sh | Jan 13, 2026 traded Jan 9, 2026 |
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K